pubmed-article:10959693 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10959693 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:10959693 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:10959693 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:10959693 | lifeskim:mentions | umls-concept:C0164707 | lld:lifeskim |
pubmed-article:10959693 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:10959693 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:10959693 | pubmed:dateCreated | 2000-11-27 | lld:pubmed |
pubmed-article:10959693 | pubmed:abstractText | Increased plasma concentrations of various markers of endothelial damage have been observed in type I diabetic patients, particularly in those with microangiopathy. | lld:pubmed |
pubmed-article:10959693 | pubmed:language | eng | lld:pubmed |
pubmed-article:10959693 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10959693 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10959693 | pubmed:month | Aug | lld:pubmed |
pubmed-article:10959693 | pubmed:issn | 0340-6245 | lld:pubmed |
pubmed-article:10959693 | pubmed:author | pubmed-author:de LeivaAA | lld:pubmed |
pubmed-article:10959693 | pubmed:author | pubmed-author:PérezAA | lld:pubmed |
pubmed-article:10959693 | pubmed:author | pubmed-author:FontcubertaJJ | lld:pubmed |
pubmed-article:10959693 | pubmed:author | pubmed-author:MaterMM | lld:pubmed |
pubmed-article:10959693 | pubmed:author | pubmed-author:SoutoJ CJC | lld:pubmed |
pubmed-article:10959693 | pubmed:author | pubmed-author:RiglaMM | lld:pubmed |
pubmed-article:10959693 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10959693 | pubmed:volume | 84 | lld:pubmed |
pubmed-article:10959693 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10959693 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10959693 | pubmed:pagination | 223-7 | lld:pubmed |
pubmed-article:10959693 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:meshHeading | pubmed-meshheading:10959693... | lld:pubmed |
pubmed-article:10959693 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10959693 | pubmed:articleTitle | Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients. | lld:pubmed |
pubmed-article:10959693 | pubmed:affiliation | Department of Endocrinology and Nutrition, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Spain. | lld:pubmed |
pubmed-article:10959693 | pubmed:publicationType | Journal Article | lld:pubmed |